Register to receive a free US Market for Female and Neonatal Diagnostic Devices – 2016 report synopsis and brochure
According to a new report on the U.S. market for female and neonatal diagnostic devices by iData Research, the largest and fastest growing segment in the breast imaging market is digital breast tomosynthesis (DBT), accounting for over 50% of the thriving breast imaging industry. DBT combines tomography with digital radiography (DR) to render an image of the breast with 3D information. A physician is able to look through multiple layers of breast tissue rather than having to see all layers in one image as in traditional 2D mammography. DBT has been taking over DR’s market. However, the DR market is still strong, with just under a quarter of the overall market.
By the end of 2015, most analog devices will have already been converted to DR mammography units. Therefore, the significant growth in DR mammography that was seen in previous years has begun to slow down. The only segment remaining to drive market growth in the breast imaging market is DBT. Forecasts show that in the near future, no analog mammography systems are expected to be sold, as they will be obsolete. The average selling price (ASP) in this market is eroding and is expected to depreciate over the forecast period. This market is transitioning into a replacement market while simultaneously being bolstered by new DBT system sales.
The conversion of analog to digital imaging systems has reached over 90%. The number of digital units in demand is reaching a plateau. This dramatically decreases the market growth rate, despite sales in DR mammography being strong in comparison to analog mammography sales. This downward trend in unit sales should continue despite the growing popularity of DBT systems.
“The ASP of DBT systems is significantly higher on average than DR mammography systems,” explains Dr. Kamran Zamanian, CEO of iData. “The drop in market value of DR systems is directly related to the recent Food and Drug Association (FDA) approvals for DBT systems by several of the large competitors in the market.” These approvals have caused these companies to shift their marketing and sales focus, thus leading to a steeper decline in DR unit sales.
As of 2015, there are three competitors with FDA approvals in the U.S. DBT market: Hologic, GE Healthcare and Siemens Healthcare. The integration of these systems in the U.S. has significantly driven growth within the breast imaging market. DBT will continue to drive growth through both increased unit sales and ASP. These increases are due to improvements in technology creating a high demand for DBT systems in a marketplace with few competitors. In addition, DBT procedures are now associated with three CPT codes and two ICD-9 codes. The creation of reimbursement opportunities for DBT procedures has spurred sales as it is now easier for health facilities to recoup the money spent and justify the high price of DBT systems.
Hologic is the leading competitor in the U.S. market for breast imaging, leading in both DR mammography and DBT markets. Other leading competitors in the breast imaging equipment market include GE Healthcare, Philips Medical Systems, Siemens Healthcare, Fujifilm, Toshiba, SuperSonic Imagine, SonoCiné, CMR-Naviscan, Hitachi, Gamma Medica Inc., Dilon Technologies, Machnet B.V., and Planmed OY among others.
For Further Information
More on the breast imaging equipment market in the US can be found in a report series published by iData Research entitled the US Market for Female and Neonatal Diagnostic Devices. The reports cover: bone densitometry, DXA markets, breast biopsy devices, core needle devices, vacuum-assisted breast biopsy devices, breast imaging equipment, mammography, obstetrics and gynecology ultrasound equipment, fetal and neonatal monitoring devices, infant warmer and incubators, NICU, and gynecological chairs.
Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
To find out more about breast imaging equipment market data or procedure data, register online or email us at [email protected] for a US Market for Female and Neonatal Diagnostic Devices report series brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.